These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 25355590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å, Nilsson L, Oleröd G, Thurin-Kjellberg A, Bergh C.
    Hum Reprod; 2017 Apr 01; 32(4):811-819. PubMed ID: 28175316
    [Abstract] [Full Text] [Related]

  • 4. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, Kuchenbecker WKH, Fleischer K, de Bruin JP, Groen H, van Wely M, Lambalk CB, Laven JSE, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group.
    Hum Reprod; 2017 Dec 01; 32(12):2485-2495. PubMed ID: 29121350
    [Abstract] [Full Text] [Related]

  • 5. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.
    Scheinhardt MO, Lerman T, König IR, Griesinger G.
    Hum Reprod; 2018 Aug 01; 33(8):1499-1505. PubMed ID: 30007353
    [Abstract] [Full Text] [Related]

  • 6. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM.
    Hum Reprod; 2015 Oct 01; 30(10):2321-30. PubMed ID: 26307091
    [Abstract] [Full Text] [Related]

  • 7. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, van Golde RJT, Hoek A, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Torrance HL, Broekmans FJM, OPTIMIST study group.
    Hum Reprod; 2019 Jun 04; 34(6):1030-1041. PubMed ID: 31125412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
    Lobo R, Soerdal T, Ekerhovd E, Cohlen B, Porcu E, Schenk M, Shufaro Y, Smeenk J, Suerdieck MB, Pinton P, Pinborg A, BEYOND Investigators .
    Hum Reprod; 2024 May 09. PubMed ID: 38723189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
    Oudshoorn SC, van Tilborg TC, Hamdine O, Torrance HL, Eijkemans MJC, Lentjes EGWM, Lambalk CB, Broekmans FJM.
    Hum Reprod; 2017 Aug 01; 32(8):1701-1709. PubMed ID: 28854580
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, Renckens CN, Bernardus RE, Schats R, Homburg R, Hompes PG, Lambalk CB.
    Hum Reprod; 2013 Oct 01; 28(10):2804-12. PubMed ID: 23838159
    [Abstract] [Full Text] [Related]

  • 14. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M, Eijkemans MJ, Broer SL, Scheffer GJ, van Rooij IA, Laven JS, Broekmans FJ.
    Hum Reprod; 2016 Jul 01; 31(7):1579-87. PubMed ID: 27179263
    [Abstract] [Full Text] [Related]

  • 15. ESHRE guideline: ovarian stimulation for IVF/ICSI†.
    Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F.
    Hum Reprod Open; 2020 Jul 01; 2020(2):hoaa009. PubMed ID: 32395637
    [Abstract] [Full Text] [Related]

  • 16. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Sep 05; 38(9):1807-1815. PubMed ID: 37354554
    [Abstract] [Full Text] [Related]

  • 17. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May 05; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 05; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 19. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

  • 20. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.
    Fertil Steril; 2013 May 01; 99(6):1644-53. PubMed ID: 23394782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.